Project Number 4R44AG071416-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for RETAIN: A digital therapeutic for Alzheimer's risk reduction Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 9. Non-Pharmacological Interventions g. Other Researcher and Organization Principal Investigator MCINNIS, MARK Principal Investigator First Name MARK Principal Investigator Last Name MCINNIS Awardee Organization RETAIN HEALTH INC Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,644,444 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MCLINDEN, KRISTINA
